Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

Spero Therapeutics, Inc. (NASDAQ:SPRO) saw its stock surge by 240% on May 28 following the company’s announcement of the ...

The AERIFY program includes two additional ongoing trials: AERIFY-3, a Phase 2 mechanistic study assessing the impact of itepekimab on airway inflammation in patients with COPD, and AERIFY-4, a Phase ...

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Merck KGaA has shown off data that fueled its $85 million bet on a late-phase treatment for a rare, locally aggressive tumor.

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...

Beginning on Tuesday, the Chiefs are conducting 10 days of voluntary organized team activities (OTAs). No live contact is ...

The Arizona Cardinals begin the final part of the offseason program on Wednesday. It is the beginning of OTAs (voluntary organized team activities).

The New York Giants begin organized team activities (OTAs) on Tuesday and here are nine things to watch over the 10 practices ...

The Tennessee Titans begin organized team activities (OTAs) on Tuesday, and here are nine things to watch over those 10 practices.